-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Zhitong Finance App, Fu'an Pharmaceutical (300194.SZ) announced that Fu'an Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received a drug registration certificate for injectable ceftazidime avibatana issued by the State Drug Administration. Injectable ceftazidime avibatana is suitable for treating complex intra-abdominal infections; hospital-acquired pneumonia and ventilator-associated pneumonia; and treatment of infections caused by gram-negative bacteria sensitive to this product in adults and children with limited treatment options.

Zhitongcaijing·08/03/2026 08:33:05
Listen to the news
According to Zhitong Finance App, Fu'an Pharmaceutical (300194.SZ) announced that Fu'an Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received a drug registration certificate for injectable ceftazidime avibatana issued by the State Drug Administration. Injectable ceftazidime avibatana is suitable for treating complex intra-abdominal infections; hospital-acquired pneumonia and ventilator-associated pneumonia; and treatment of infections caused by gram-negative bacteria sensitive to this product in adults and children with limited treatment options.